`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`
`
`JEFFREY B. CLARK
`Acting Assistant Attorney General
`Civil Division
`DANIEL J. FEITH
`Deputy Assistant Attorney General
`GUSTAV W. EYLER
`Director
`KENDRACK D. LEWIS
`Trial Attorney
`Consumer Protection Branch
`U.S. Department of Justice, Civil Division
`P.O. Box 386
`Washington, D.C. 20044
`Telephone: (202) 353-3881
`Fax: (202) 514-8742
`WILLIAM D. HYSLOP
`United States Attorney (EDWA)
`TIMOTHY M. DURKIN
`Civil Chief, Asst. U.S. Attorney
`Post Office Box 1494
`Spokane, WA 99210-1494
`Telephone: (509) 353-2767
`
`Attorneys for Plaintiff
`
`
`UNITED STATES DISTRICT COURT
`EASTERN DISTRICT OF WASHINGTON
`
`
`
`
`UNITED STATES OF
`AMERICA,
`
`Plaintiff,
`
`v.
`
`VALLEY PROCESSING, INC., a
`corporation, and MARY ANN BLIESNER,
`individually,
`
`
`Defendants.
`
`
`
`
`
`
`
`
`
`Case No. 1:20-cv-3191
`
`COMPLAINT FOR PERMANENT
`INJUNCTION
`
`
`Plaintiff United States of America, by and through its undersigned attorneys,
`
` 1
`
`Complaint for Permanent Injunction
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`
`
`
`
`Case 1:20-cv-03191-SAB ECF No. 1 filed 11/06/20 PageID.2 Page 2 of 20
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`
`
`respectfully represents as follows:
`
`INTRODUCTION
`
`1. The United States of America brings this action on behalf of the United States
`
`Food and Drug Administration (“FDA”) pursuant to the Federal Food, Drug, and
`
`Cosmetic Act (the “Act”), 21 U.S.C. § 332(a), to permanently enjoin and restrain Valley
`
`Processing, Inc. (“Valley Processing”) and Mary Ann Bliesner (collectively,
`
`“Defendants”), from introducing or delivering for introduction into interstate commerce,
`
`or the causing thereof, food that is adulterated, in violation of 21 U.S.C. § 331(a), and
`
`causing such food to become adulterated while it is held for sale after shipment of one or
`
`more of its components in interstate commerce, in violation of 21 U.S.C. § 33l(k).
`
`JURISDICTION AND VENUE
`
`2. This Court has jurisdiction under 21 U.S.C. § 332(a) and 28 U.S.C. §§ 1331,
`
`1337, and 1345, and personal jurisdiction over all parties.
`
`3. Venue in this district is proper pursuant to 28 U.S.C. § 1391(b) and (c).
`
`DEFENDANTS
`
`4. Defendant Valley Processing is a Washington corporation previously
`
`headquartered at 108 Blaine Ave., Sunnyside, Washington 98944. Valley Processing
`
`manufactured single strength fruit juice and fruit juice concentrate, including bulk apple,
`
`pear, and grape juice products distributed in pails, barrels, totes, and tanker trucks. The
`
`company was incorporated on July 16, 1980, and had seventy-one (71) employees. The
`
`company supplied apple juice through one customer to the United States Department of
` 2
`
`Complaint for Permanent Injunction
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`
`
`
`
`Case 1:20-cv-03191-SAB ECF No. 1 filed 11/06/20 PageID.3 Page 3 of 20
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`
`
`Agriculture (“USDA”) school lunch program, providing approximately 2,964,000 apple
`
`juice servings to schoolchildren every year. The company’s facilities included three
`
`manufacturing plants, an ambient warehouse (“Mojo Warehouse”), a cold room, and
`
`three coolers, all located at the Blaine Avenue location. In addition to the Blaine Avenue
`
`facilities, Defendants also stored product in an ambient storage facility, where product
`
`was stored outside, located at 130 US Grape Road, Sunnyside, Washington 98944, and in
`
`another storage room known as the Briner Cold Room, located in the maintenance
`
`building at 105 South First Street, Sunnyside, Washington, 98944.
`
`5. Defendant Mary Ann Bliesner is Valley Processing’s Owner, President,
`
`Secretary, and Treasurer. At all times relevant to the allegations in this Complaint, Ms.
`
`Bliesner was responsible for the day-to-day management of the company’s juice
`
`production facility, including supervising and training employees. She was the most
`
`responsible person at the company, overseeing operations, and had the authority to take
`
`corrective actions, as well as the authority to hire and fire employees.
`
` HEALTH RISKS ASSOCIATED WITH DEFENDANTS’ PRODUCTS
`
`6. Defendants’ juice products have been found to contain inorganic arsenic and
`
`patulin, both toxins which pose a health risk to consumers.
`
`7. Arsenic is an element that occurs in the environment from both natural and
`
`manmade sources, including the erosion of arsenic-containing rocks, volcanic eruptions,
`
`contamination from mining and smelting ores, and previous or current use of arsenic-
`
`containing pesticides. Arsenic is found in both inorganic and organic forms, and
` 3
`
`Complaint for Permanent Injunction
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`
`
`
`
`Case 1:20-cv-03191-SAB ECF No. 1 filed 11/06/20 PageID.4 Page 4 of 20
`
`
`
`inorganic arsenic is generally considered more toxic than organic arsenic. Exposure to
`
`inorganic arsenic has been associated with cancer, skin lesions, cardiovascular disease,
`
`neurotoxicity and diabetes in humans. Inorganic arsenic is a hazard that is reasonably
`
`likely to occur in processing both apple and pear juice products. Thermal processing,
`
`including pasteurization, does not destroy arsenic.
`
`8. Patulin is a mycotoxin produced by certain species of molds that may grow on
`
`a variety of foods, including apples and pears. High levels of patulin can be produced in
`
`rotting or moldy apples or pears. Apples and pears that have been damaged, by falling off
`
`the tree, by insects or birds, or by rough handling, are more susceptible to the growth of
`
`patulin producing molds. Storage of apples under conditions that do not control mold
`
`growth can also lead to high levels of patulin. If fallen fruit, moldy, rotten, bruised,
`
`damaged, or improperly stored apples are used to make juice, high levels of patulin can
`
`occur in the juice even if it is pasteurized. Thermal processing, including pasteurization,
`
`does not destroy patulin.
`
`9. Exposure to high levels of patulin over time may pose health hazards in
`
`humans, including nausea, vomiting, and gastrointestinal disturbances. FDA has
`
`established an action level of 50 parts per billion (“ppb”) in apple juice. Patulin can be
`
`destroyed by fermentation, so it is not found in either alcoholic beverages or vinegars
`
`produced from apple or pear juices.
`
`
`
`
` 4
`
`Complaint for Permanent Injunction
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`
`
`
`
`Case 1:20-cv-03191-SAB ECF No. 1 filed 11/06/20 PageID.5 Page 5 of 20
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`
`
`REGULATORY FRAMEWORK
`
`10. Defendants’ juice products are food within the meaning of the Act, 21 U.S.C.
`
`§321(1).
`
`11. FDA’s food current good manufacturing practice (“CGMP”) regulations
`
`establish basic practices that must be followed, and conditions that must be maintained,
`
`by entities or individuals, like Defendants, who receive, prepare, process, pack, hold, or
`
`distribute food. See 21 C.F.R. Part 117 subpart B. The purpose of CGMP is to ensure that
`
`food is processed in a safe and sanitary manner.
`
`12. Juice processors must monitor, with sufficient frequency, their sanitation
`
`conditions and practices used during processing to ensure, at a minimum, that they
`
`conform with CGMP regulations for manufacturing, packing, or holding human food,
`
`see, e.g., 21 C.F.R. Part 117 subpart B. 21 C.F.R. § l 20.6(b). Violations of CGMP help to
`
`determine whether the facilities, methods, practices, and controls used to process juices
`
`are sanitary and safe. 21 C.F.R. § 120.5; see also 21 C.F.R. Part 117 subpart B.
`
`13. Defendants are also subject to the juice Hazard Analysis and Critical Control
`
`Point (“HACCP”) regulation, 21 C.F.R. Part 120, because they manufacture juice
`
`products that are both sold as juice and that are “used as an ingredient in beverages,” see
`
`21 C.F.R. § 120.1, and because Defendants’ manufacturing operations constitute
`
`“processing,” as defined by 21 C.F.R. § 120.3(i)(l).
`
`14. The juice HACCP regulation, 21 C.F.R. Part 120, creates a system to prevent
`
`the occurrence of potential food hazards in juice. HACCP achieves this goal by requiring
` 5
`
`Complaint for Permanent Injunction
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`
`
`
`
`Case 1:20-cv-03191-SAB ECF No. 1 filed 11/06/20 PageID.6 Page 6 of 20
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`
`
`juice processors to assess their processing operations (known as the hazard analysis),
`
`identify points in the process at which various hazards may occur (known as critical
`
`control points), and establish measures to control, prevent, or eliminate those hazards
`
`(known as critical limits). See 21 C.F.R. §§ 120.7-120.13.
`
`15. Under the juice HACCP regulation, every juice processor must develop, or
`
`have developed for it, a written hazard analysis to determine whether there are food
`
`hazards that are reasonably likely to occur during processing for each type of juice
`
`produced and to identify control measures that the processor can apply to control those
`
`hazards. 21 C.F.R. § 120.7(a). Whenever a hazard analysis identifies one or more food
`
`hazards that are reasonably likely to occur during processing, the processor must have
`
`and implement a written HACCP plan to control the identified food hazards. 21 C.F.R. §
`
`120.8.
`
`16. Additionally, a juice processor’s HACCP plan must identify “critical control
`
`points” (“CCPs”) in the juice manufacturing process at which a control measure can be
`
`applied that “is essential to reduce an identified food hazard to an acceptable limit.” 21
`
`C.F.R. §§ 120.3(d), 120.7(a)(5).
`
`17. For each CCP, the HACCP plan must establish a “critical limit,” i.e., the
`
`“maximum or minimum value to which a physical, biological, or chemical parameter
`
`must be controlled ... to prevent, eliminate, or reduce to an acceptable level, the
`
`occurrence of the identified food hazard.” 21 C.F.R. §§ 120.3(e), 120.8(b)(3).
`
`18. The juice HACCP regulation further requires that juice processors have and
` 6
`
`Complaint for Permanent Injunction
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`
`
`
`
`Case 1:20-cv-03191-SAB ECF No. 1 filed 11/06/20 PageID.7 Page 7 of 20
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`
`
`implement a sanitation standard operating procedure that addresses sanitation conditions
`
`and practices before, during, and after processing. 21 C.F.R. § 120.6.
`
`19. Under the Act, 21 U.S.C. § 342(a)(4), food is adulterated if it has been
`
`“prepared, packed or held under insanitary conditions whereby it may have become
`
`contaminated with filth, or whereby it may have been rendered injurious to health.”
`
`20. Under the Act, 21 U.S.C. § 342(a)(3), food is adulterated if “it consists in
`
`whole or in part of any filthy, putrid, decomposed substance, or if it is otherwise unfit for
`
`food.”
`
`21. Juice products that are processed without adhering to the CGMP requirements
`
`or the juice HACCP regulation are adulterated within the meaning of 21 U.S.C. §
`
`342(a)(4).
`
`22. In addition, juice products are adulterated under 21 U.S.C. § 342(a)(4) when a
`
`manufacturer’s quality control operations do not ensure food is suitable for human
`
`consumption. See 21 C.F.R. § 117.1(a)(1)(ii); 21 C.F.R. § 117.80(a)(2).
`
`DEFENDANTS’ VIOLATIONS
`
`23. Defendants violated 21 U.S.C. § 331(a) by introducing or delivering for
`
`introduction into interstate commerce, or the causing thereof, food that is adulterated
`
`within the meaning of 21 U.S.C. § 342(a)(4) and 21 U.S.C. § 342(a)(3).
`
`24. Defendants violated 21 U.S.C. § 331(k) because they cause food held for sale
`
`after shipment of one or more components in interstate commerce to become adulterated
`
`within the meaning of 21 U.S.C. § 342(a)(4) and 21 U.S.C. § 342(a)(3).
` 7
`
`Complaint for Permanent Injunction
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`
`
`
`
`Case 1:20-cv-03191-SAB ECF No. 1 filed 11/06/20 PageID.8 Page 8 of 20
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`
`
`25. Defendants distributed their juice products in interstate commerce to
`
`customers located in California.
`
`
`
`26. Defendants received tartaric acid, a preservative used in their juice products,
`
`from a supplier in Spain.
`
`27. Defendants’ juice products are adulterated within the meaning of 21 U.S.C. §
`
`342(a)(4), in that they have been prepared, packed, or held under insanitary conditions
`
`whereby they may have been contaminated with filth, or whereby they may have been
`
`rendered injurious to health. In addition, because Defendants’ juice products are
`
`processed without adhering to the requirements of 21 C.F.R. Part 120, they are
`
`adulterated within the meaning of 21 U.S.C. § 342(a)(4). See 21 C.F.R. § 120.9.
`
`Defendants’ failure to have and implement an adequate HACCP plan created insanitary
`
`conditions that may render their juice injurious to health. See 21 C.F.R. § 120.9.
`
`28. In addition, Defendants’ juice products “consist[] in whole or in part of any
`
`filthy, putrid, or decomposed substance” or are “otherwise unfit for food,” and thus are
`
`adulterated under 21 US.C. § 342(a)(3).
`
`FDA INSPECTIONS
`
`29. Defendants have an extensive history of processing juice under grossly
`
`insanitary conditions and with an inadequate HACCP plan that has not been properly or
`
`fully implemented. This pattern of continuing violative conduct has been documented by
`
`FDA investigators during inspections on May 6 to June 20, 2019 (the “June 2019
`
`inspection”); April 30 to July 31, 2018 (the “July 2018 inspection”); March 28 to April
` 8
`
`Complaint for Permanent Injunction
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`
`
`
`
`Case 1:20-cv-03191-SAB ECF No. 1 filed 11/06/20 PageID.9 Page 9 of 20
`
`
`
`26, 2017 (the “April 2017 inspection”); and December 7, 2015, to January 29, 2016 (the
`
`“January 2016 inspection”).
`
`30. Although FDA found violations of CGMP and HACCP during all inspections,
`
`as discussed further below, during the July 2018 inspection, FDA investigators learned
`
`that Defendants were storing grape juice concentrate outside in covered barrels at
`
`ambient temperatures at a previously undisclosed facility on US Grape Road. Many of
`
`these barrels contained grape juice concentrate that was several years old, with some lot
`
`codes dating back to 2008. As confirmed by FDA sampling, the grape juice concentrate
`
`in these barrels was contaminated by filth and mold, and thus not suitable for human
`
`consumption.
`
`31. FDA investigators also discovered that Defendants processed the “bottoms”
`
`of stored grape juice concentrate. The “bottom” of juice concentrate is the leftover sludge
`
`that accumulates at the bottom of the barrel, after Defendants open a barrel to pull
`
`product off the top, exposing all of the product in the barrel to possible contamination.
`
`Defendants diluted the “bottoms,” likely to contain contaminants, to be blended with
`
`newer juice. Defendants mixed the juice concentrate from the both the ambient barrels
`
`and the “bottoms” with newer lots to hide the contamination. Defendants promised to
`
`stop both of these practices, described in paragraphs 30 and 31, but as detailed below,
`
`FDA investigators confirmed during the June 2019 inspection that Defendants continued
`
`both of them.
`
`
` 9
`
`Complaint for Permanent Injunction
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`
`
`
`
`Case 1:20-cv-03191-SAB ECF No. 1 filed 11/06/20 PageID.10 Page 10 of 20
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`
`
`Most Recent Inspection
`
`32. During the June 2019 inspection, FDA investigators observed multiple
`
`violations of the CGMP requirements, as the Defendants continued their grossly
`
`insanitary manufacturing and storage practices for their juice products, and recurring
`
`HACCP violations.
`
`CGMP Violations
`
`33. Defendants failed to comply with 21 C.F.R. § 120.6(b), which requires them
`
`to monitor sanitation conditions and practices with sufficient frequency during juice
`
`processing to ensure conformance with CGMP, as set forth in 21 C.F.R. Part 110 and 21
`
`C.F.R. Part 117, subpart B. FDA investigators observed numerous deviations from
`
`CGMP including, but not limited to, the following:
`
`a. Defendants did not have appropriate quality control operations to ensure
`
`that food is fit for human consumption, as required by 21 C.F.R. § 117.80(a)(2). During
`
`the June 2019 inspection, FDA investigators observed that, despite Defendants’ promises
`
`to stop the practice both during and following the July 2018 inspection, Defendants
`
`continued to blend grape juice concentrate with lot numbers dating back to 2011, and
`
`stored outside at ambient temperatures, with newer product. FDA investigators also
`
`observed that quality processes that Defendants developed and implemented to ensure
`
`that all blended products were fit for human consumption were inadequate as written and
`
`were often not followed;
`
`
` b. Defendants did not conduct their operations under conditions and controls
` 10
`
`Complaint for Permanent Injunction
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`
`
`
`
`Case 1:20-cv-03191-SAB ECF No. 1 filed 11/06/20 PageID.11 Page 11 of 20
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`
`
`necessary to minimize the potential for contamination of food, as required by 21 C.F.R. §
`
`117.80(c). Specifically, during the 2019 inspection, FDA investigators observed
`
`Defendants continuing to blend “bottoms,” likely to contain contaminants, with newer
`
`juice. Defendants still used this process despite being told at the July 2018 inspection by
`
`FDA that this process could make the blended juice unfit for human consumption and
`
`promising to FDA investigators that they would discontinue this practice;
`
`c. Defendants did not maintain their facility in a clean and sanitary condition
`
`or keep the facility in good repair, as required by 21 C.F.R. § 117.35(a). For example,
`
`FDA investigators observed gaps in the walls of the Briner Cold Room and the Mojo
`
`Warehouse leading directly outside and liquid leaking from a hole in the roof at the Mojo
`
`Warehouse onto cleaning materials;
`
` d. Defendants failed to exclude pests from their facility to protect against
`
`contamination of food, as required by 21 C.F.R. § 117.35(c). For example, FDA
`
`investigators observed a dead squirrel on the floor of, and live birds flying in, the Mojo
`
`Warehouse, and bird feathers, bird excreta, and insect fragments on barrels holding juice
`
`concentrate in the Briner Cold Room; and
`
`e. Defendants failed to develop any sanitation standard operating procedures
`
`(“SSOPs”), or monitor sanitation with sufficient frequency, in several locations at their
`
`facility, as required by 21 C.F.R. § 120.6(b). Specifically, FDA investigators observed
`
`that Defendants did not have any SSOPs or sanitation monitoring records for the Briner
`
`Cold Room or US Grape Road. Defendants had a sanitation monitoring record for the
` 11
`
`Complaint for Permanent Injunction
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`
`
`
`
`Case 1:20-cv-03191-SAB ECF No. 1 filed 11/06/20 PageID.12 Page 12 of 20
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`
`
`Mojo Warehouse that recorded conditions on a weekly basis, but the record from five
`
`days before the inspection showed no insanitary conditions, while FDA investigators
`
`observed egregious insanitary conditions, including a dead squirrel, live birds, bird and
`
`mouse excreta at that location. Defendants did not have an SSOP for the Mojo
`
`Warehouse.
`
`HACCP Violations
`
`34. During the June 2019 inspection, FDA investigators observed that
`
`Defendants had not adequately corrected the HACCP violations that FDA previously
`
`noted related to the control of inorganic arsenic in apple and pear juice products, and
`
`patulin in apple and pear juice products. These HACCP violations were the same or
`
`similar to previous inspections, including, but not limited to:
`
`a. Defendants failed to adequately implement the monitoring procedures at
`
`critical control points that they identified in their HACCP plans, in violation of 21 C.F.R.
`
`§ 120.8. For example:
`
`(i) Defendants’ HACCP plan to control inorganic arsenic required
`
`Defendants to sample apple juice products for total arsenic levels, and to perform
`
`additional testing to determine inorganic arsenic levels if total arsenic levels are above 10
`
`ppb and less than 12 ppb. FDA investigators observed that one lot of apple juice
`
`contained 28 ppb total arsenic, but Defendants did not test the inorganic arsenic levels or
`
`divert the lot from distribution;
`
`(ii) Defendants also failed to monitor the critical limits for patulin in
` 12
`
`Complaint for Permanent Injunction
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`
`
`
`
`Case 1:20-cv-03191-SAB ECF No. 1 filed 11/06/20 PageID.13 Page 13 of 20
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`
`
`their apple and pear juice products. Defendants’ HACCP plan included the critical limit
`
`to control patulin: “No visible rotten, moldy or deteriorating apples or pears.” But during
`
`a ten-minute period at the June 2019 inspection, FDA investigators observed
`
`approximately 46 apples that were visibly deteriorated with mold and rot pass through the
`
`sorting/culling critical control point;
`
`b. Defendants failed to adequately implement corrective actions identified
`
`in their HACCP plans, in violation of 21 C.F.R. § 120.l0(a). For example:
`
`(i) Defendants’ HACCP plans to control inorganic arsenic for both
`
`apple and pear juice products included the following corrective actions for the detection
`
`of high levels of inorganic arsenic: “high levels will be investigated, analyzed, and
`
`trended to ascertain potential origin of high arsenic” and “supplier may be removed from
`
`supplier list if found to be source of contamination.” During the June 2019 inspection,
`
`FDA investigators found that 17 lots of apple juice products produced between July 31,
`
`2018, the date of the close of the previous FDA inspection, and April 10, 2019, had total
`
`arsenic levels that exceeded 12 ppb, and 2 lots of pear juice products produced between
`
`the same dates had total arsenic levels that exceeded 23 ppb. Defendants only collected
`
`the total arsenic data but did not investigate, analyze, or trend the data to determine the
`
`cause of the high arsenic in the juice products;
`
`(ii) Defendants’ HACCP plan to control patulin also required that they
`
`investigate, track, or trend any patulin levels above the critical limit of 50 ppb to
`
`determine the cause. FDA investigators found no evidence that Defendants investigated,
` 13
`
`Complaint for Permanent Injunction
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`
`
`
`
`Case 1:20-cv-03191-SAB ECF No. 1 filed 11/06/20 PageID.14 Page 14 of 20
`
`
`
`tracked, or trended any patulin levels above the critical limit of 50 ppb; and
`
`
`
`c. Defendants failed to identify an appropriate critical limit for controlling
`
`a known hazard, as required by 21 C.F.R. § 120.8(a)(3). For example, FDA investigators
`
`found that in October 2018, Defendants changed their HACCP plan for control of patulin,
`
`raising the critical limit for core rot at the sort/cull critical control point from less than 1%
`
`to less than 10%, meaning that whereas they had previously accepted for processing any
`
`apple consisting of 1% or less of core rot they now process any apple consisting of 10%
`
`or less of core rot. Defendants made this change in their written HACCP plan despite a
`
`history of high patulin levels and after being advised by FDA that apples with a small
`
`percentage of rot can produce juice with high levels of patulin. When questioned by FDA
`
`investigators about the change, Defendant Mary Ann Bliesner was unaware of the
`
`change, despite signing the revised HACCP plan, and could not provide any scientific
`
`justification or support for the change.
`
`Previous Inspections
`
`
`
`35. FDA investigators observed significant ongoing violations of the Act, the
`
`CGMP requirements, and the juice HACCP regulations during its July 2018, April 2017,
`
`and January 2016 inspections, and issued Lists of Inspectional Observations (“Forms
`
`FDA-483”) at the conclusion of each inspection. The Forms FDA-483 included
`
`observations of the same type of deficiencies observed at the June 2019 inspection.
`
`
`
`
` 14
`
`Complaint for Permanent Injunction
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`
`
`
`
`Case 1:20-cv-03191-SAB ECF No. 1 filed 11/06/20 PageID.15 Page 15 of 20
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`
`
`Previous CGMP Violations
`
`36. At all three previous inspections, FDA investigators observed that
`
`Defendants failed to comply with 21 C.F.R. § 120.6(b) that required them to monitor
`
`sanitation conditions and practices with sufficient frequency during juice processing to
`
`ensure conformance with CGMP, as set forth in 21 C.F.R. Part 110 and 21 C.F.R. Part
`
`117, subpart B. FDA investigators observed numerous deviations from CGMP including,
`
`but not limited to, the following:
`
`a. Defendants did not have appropriate quality control operations to ensure
`
`that food is fit for human consumption, as required by 21 C.F.R. § 117.80(a)(2). For
`
`example, during the 2018 inspection, FDA investigators discovered Defendants were
`
`storing years old grape juice concentrate outside in covered barrels at ambient
`
`temperatures. The grape juice concentrate in these barrels was contaminated by filth and
`
`mold, and thus not suitable for human consumption. Defendants mixed the juice
`
`concentrate from these barrels with newer lots to hide the contamination;
`
`b. Defendants did not conduct their operations under conditions and
`
`controls necessary to minimize the potential for contamination of food, as required by 21
`
`C.F.R. § 117.80(c). FDA investigators also discovered in 2018 that Defendants process
`
`the “bottoms” of stored grape juice concentrate. The “bottom” of juice concentrate is the
`
`leftover sludge that accumulates at the bottom of the barrel, after Defendants open a
`
`barrel to pull product off the top, exposing all of the product in the barrel to possible
`
`contamination. Defendants dilute the “bottoms,” likely to contain contaminants, to be
` 15
`
`Complaint for Permanent Injunction
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`
`
`
`
`Case 1:20-cv-03191-SAB ECF No. 1 filed 11/06/20 PageID.16 Page 16 of 20
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`
`
`blended with newer juice;
`
`c. Defendants failed to exclude pests from their facility to protect against
`
`contamination of food, as required by 21 C.F.R. § 117.35(c). During the 2018, 2017, and
`
`2016 inspections, FDA investigators observed numerous live and dead animals, including
`
`mice, rats, squirrels, and birds, throughout various buildings used for both storage and
`
`manufacturing. In several instances, FDA investigators also observed rodent excreta on
`
`top of the barrels used to store juice products; and
`
`d. Defendants failed to monitor sanitation conditions and practices with
`
`sufficient frequency during juice processing to ensure conformance with CGMP, as
`
`required by 21 C.F.R. § l 20.6(b). For example, during the 2018 inspection, FDA
`
`investigators found that Defendants’ sanitation records did not reflect any of the
`
`insanitary conditions that FDA investigators observed, and Defendants’ sanitation
`
`program excluded the US Grape Road location and the Mojo Warehouse.
`
`Previous HACCP Violations
`
`37. During all three previous inspections, FDA investigators observed recurring
`
`significant HACCP violations related to the control of inorganic arsenic in apple and pear
`
`juice products and patulin in apple and pear juice products. These HACCP violations
`
`included, but were not limited to:
`
`a. Defendants failed to adequately implement the monitoring procedures at
`
`CCPs that they had identified in their HACCP plans, in violation of 21 C.F.R. § 120.8.
`
`Specifically, at all three previous inspections, Defendants failed to adequately monitor
` 16
`
`Complaint for Permanent Injunction
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`
`
`
`
`Case 1:20-cv-03191-SAB ECF No. 1 filed 11/06/20 PageID.17 Page 17 of 20
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11